U.S. Medical Marijuana Market Size & Share 2022 to 2030

Market Size by Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures), by Route of Administration, (Inhalation, Oral, Topical), by Distribution Channel (Dispensaries, Online) & Forecast.
Report ID: GMI2890
   |
Published Date: October 2022
 | 
Report Format: PDF

Download Free PDF

U.S. Medical Marijuana Market Size

U.S. Medical Marijuana Market size was worth more than USD 9 billion in 2021 and is anticipated to exhibit 10% CAGR between 2022 to 2030.
 

Increasing awareness regarding the health benefits of cannabis and cannabidiol (CBD) to treat various clinical conditions will boost the market landscape. CBD is a non-impairing compound found in marijuana that does not induce euphoria. It has multiple health benefits including pain management, appetite enhancement, reduced eye pressure, and many more.
 

U.S. Medical Marijuana Market

The United States Food and Drug Administration (FDA) encourages new drug development efforts and is steadily authorizing medicines containing therapeutic compounds derived from cannabis. The product could help treat patients of age one year and above with seizures caused by tuberous sclerosis complex (TSC).
 

 

Strict federal laws against cannabis production in some states may impede industry across the U.S. As per federal law, cannabis remains illegal and banks in the U.S. are under strict compliance with the government to avoid taking funds from marijuana businesses. The lack of a policy framework pertaining to the production and sale of marijuana in many parts of the country may hinder the U.S. medical marijuana market forecasts.
 

U.S. Medical Marijuana Market Analysis

U.S. Medical Marijuana Market Share By Application

U.S. medical marijuana market from pain management segment was over USD 7 billion in 2021. Rising incidences of neuropathic and chronic pain cases in the U.S. has accelerated the need for novel therapeutic options. According to data provided by the CDC, more than 20% of American adults live with chronic pain. Marijuana is seen as a potential alternative to traditional chronic pain medication.
 

Studies suggest that medical marijuana may be a good treatment option for people with fibromyalgia as it contains compounds that could offer relief from some of its symptoms. Patients of fibromyalgia may experience pain and headaches along with several other indications. Government efforts to legalize the substance for medical purposes will enable its use in the production of novel chronic pain medications.
 

In terms of the distribution channel, the U.S. medical marijuana market is bifurcated into dispensaries, and online platforms. The dispensaries segment is projected to exhibit a 10% CAGR between 2022-2030. Several U.S. states are allowing patients to purchase medical marijuana products from authorized local dispensaries. Authorized procurement and sale of cannabis-infused medical products helps the local governments to effectively check whether the distribution is performed legally. Increasing initiatives in favor of marijuana legalization will enable the deployment of authorized dispensaries in the country.
 

U.S. Medical Marijuana Market By Zones

South Atlantic U.S. medical marijuana market is poised to surpass USD 3 billion by 2030. Significant progress in the patient population across the state will fuel the demand for suitable CBD products. A favorable licensing scenario is accelerating cannabis production across South Atlantic. Increasing awareness regarding the health benefits of the substance will further drive the sales of medical marijuana across South Atlantic U.S.
 

U.S. Medical Marijuana Market Share

Some of the leading companies in the U.S. medical marijuana market are:

  • Aurora Cannabis Inc
  • GW Pharmaceuticals
  • Cannabis Sativa Inc
  • Emerald Health Therapeutics Inc
  • The Cronos Group Inc
  • Tilray
  • Lexaria Bioscience Corp
  • Curaleaf
  • Green Roads
  • CHARLOTTE’S WEB
  • Canopy Growth Corporation
  • Gaia Herbs
  • Medical Marijuana
  • Folium Biosciences.

These companies are focusing on product commercialization and patents by means of collaboration with related firms.
 

Impact of COVID-19 Pandemic

The COVID-19 pandemic led to a dramatic rise in the consumption of health supplements and nutraceuticals, creating a positive outlook for U.S. medical marijuana industry. In the wake of the pandemic, a significant rise in prescriptions for medical marijuana patients was seen across the U.S. This led to ramping up of production of cannabis for medicinal purposes. Despite supply chain disruptions, domestic marijuana producers reported high product demand on account of the growing popularity of cannabis supplements.
 

The U.S. medical marijuana market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2030 for the following segments:

By Application                

  • Pain Management
    • Neuropathic Pain
    • Cancer Pain
    • Others
  • Muscle Spasms
  • Nausea
  • Anorexia
  • Seizures
  • Others

By Route of Administration

  • Inhalation
  • Oral
  • Topical

By Distribution Channel

  • Dispensaries
  • Online

The above information is provided for the following zones and states:

  • North East
    • Connecticut
    • Maine
    • Massachusetts
    • New Hampshire
    • Rhode Island
    • Vermont
    • New Jersey
    • New York
    • Pennsylvania
  • East North Central
    • Illinois
    • Michigan
    • Ohio
  • South Atlantic
    • Delaware
    • Florida
    • Maryland
    • Washington D.C.
    • Virginia
    • West Virginia
  • West North Central
    • Minnesota
    • Missouri
    • North Dakota
    • South Dakota
  • Pacific Central
    • Alaska
    • California
    • Hawaii
    • Oregon
    • Washington
  • Mountain States
    • Arizona
    • Colorado
    • Nevada
    • New Mexico
    • Montana
    • Utah
  • West South Central
    • Arkansas
    • Louisiana
    • Oklahoma

 

Authors: Mariam Faizullabhoy, Gauri Wani
U.S. Medical Marijuana Market Scope
  • U.S. Medical Marijuana Market Size
  • U.S. Medical Marijuana Market Trends
  • U.S. Medical Marijuana Market Analysis
  • U.S. Medical Marijuana Market Share

Report Content

Chapter 1   Methodology

1.1    Market definition

1.2    Base estimates & working

1.3    Forecast parameters

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1   Paid sources

1.5.1.2   Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    U.S. medical marijuana industry 3600 synopsis, 2017 - 2030

2.1.1    Business trends

2.1.2    Application trends

2.1.3    Route of administration trends

2.1.4    Distribution channel trends

2.1.5    Zonal trends

Chapter 3   US Medical Marijuana Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2030

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Increasing application of marijuana for a myriad of medical conditions and symptoms

3.3.1.2   Growing demand for medical marijuana legalization in several countries

3.3.1.3   Rising number of R&D and clinical trial activities

3.3.2    Industry pitfalls & challenges

3.3.2.1   Few side effects might hinder the market growth

3.3.2.2   Difficulty in medical marijuana business banking

3.4    Growth potential analysis

3.4.1    By application

3.4.2    By route of administration

3.4.3    By distribution channel

3.5    COVID-19 impact analysis

3.6    Regulatory landscape & guidelines

3.6.1    Alaska

3.6.2    Arizona

3.6.3    Arkansas

3.6.4    California

3.6.5    Colorado

3.6.6    Connecticut

3.6.7    Delaware

3.6.8    Florida

3.6.9    Hawaii

3.6.10    Illinois

3.6.11    Louisiana

3.6.12    Maine

3.6.13    Maryland

3.6.14    Massachusetts

3.6.15    Michigan

3.6.16    Minnesota

3.6.17    Montana

3.6.18    Missouri

3.6.19    Nevada

3.6.20    New Hampshire

3.6.21    New Jersey

3.6.22    New Mexico

3.6.23    New York

3.6.24    North Dakota

3.6.25    Pennsylvania

3.6.26    Ohio

3.6.27    Oklahoma

3.6.28    Oregon

3.6.29    Rhode Island

3.6.30    South Dakota

3.6.31    Utah

3.6.32    Virginia

3.6.33    Vermont

3.6.34    West Virginia

3.6.35    Washington

3.6.36    Washington D.C.

3.7    Value chain analysis

3.8    Legal requirement for distribution of medical marijuana

3.9    Porter’s analysis

3.10    Competitive landscape, 2021

3.10.1    Company matrix analysis, 2021

3.11    PESTEL analysis

Chapter 4   US Medical Marijuana Market, By Application

4.1    Key segment trends

4.2    Pain Management

4.2.1    Market size, by zones, 2017 - 2030 (USD Million)

4.2.2    Neuropathic pain

4.2.2.1   Market size, by zones, 2017 - 2030 (USD Million)

4.2.3    Cancer pain

4.2.3.1   Market size, by zones, 2017 - 2030 (USD Million)

4.2.4    Others

4.2.4.1   Market size, by zones, 2017 - 2030 (USD Million)

4.3    Muscle spasms

4.3.1    Market size, by zones, 2017 - 2030 (USD Million)

4.4    Nausea

4.4.1    Market size, by zones, 2017 - 2030 (USD Million)

4.5    Anorexia

4.5.1    Market size, by zones, 2017 - 2030 (USD Million)

4.6    Seizures

4.6.1    Market size, by zones, 2017 - 2030 (USD Million)

4.7    Others

4.7.1    Market size, by zones, 2017 - 2030 (USD Million)

Chapter 5   US Medical Marijuana Market, By Route of Administration

5.1    Key segment trends

5.2    Inhalation

5.2.1    Market size, by zones, 2017 - 2030 (USD Million)

5.3    Oral

5.3.1    Market size, by zones, 2017 - 2030 (USD Million)

5.4    Topical

5.4.1    Market size, by zones, 2017 - 2030 (USD Million)

Chapter 6   US Medical Marijuana Market, By Distribution Channel

6.1    Key segment trends

6.2    Dispensaries

6.2.1    Market size, by zones, 2017 - 2030 (USD Million)

6.3    Online

6.3.1    Market size, by zones, 2017 - 2030 (USD Million)

Chapter 7   US Medical Marijuana Market, By Zone

7.1    Key zonal trends

7.2    North East

7.2.1    Market size, by states, 2017 - 2030 (USD Million)

7.2.2    Market size, by application, 2017 - 2030 (USD Million)

7.2.2.1   Market size, by pain management, 2017 - 2030 (USD Million)

7.2.3    Market size, by route of administration, 2017 - 2030 (USD Million)

7.2.4    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.2.5    Connecticut

7.2.5.1   Market size, by application, 2017 - 2030 (USD Million)

7.2.5.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.2.5.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.2.5.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.2.6    Maine

7.2.6.1   Market size, by application, 2017 - 2030 (USD Million)

7.2.6.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.2.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.2.6.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.2.7    Massachusetts

7.2.7.1   Market size, by application, 2017 - 2030 (USD Million)

7.2.7.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.2.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.2.7.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.2.8    New Hampshire

7.2.8.1   Market size, by application, 2017 - 2030 (USD Million)

7.2.8.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.2.8.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.2.8.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.2.9    Rhode Island

7.2.9.1   Market size, by application, 2017 - 2030 (USD Million)

7.2.9.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.2.9.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.2.9.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.2.10    Vermont

7.2.10.1    Market size, by application, 2017 - 2030 (USD Million)

7.2.10.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.2.10.2    Market size, by route of administration, 2017 - 2030 (USD Million)

7.2.10.3    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.2.11    New Jersey

7.2.11.1    Market size, by application, 2017 - 2030 (USD Million)

7.2.11.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.2.11.2    Market size, by route of administration, 2017 - 2030 (USD Million)

7.2.11.3    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.2.12    New York

7.2.12.1    Market size, by application, 2017 - 2030 (USD Million)

7.2.12.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.2.12.2    Market size, by route of administration, 2017 - 2030 (USD Million)

7.2.12.3    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.2.13    Pennsylvania

7.2.13.1    Market size, by application, 2017 - 2030 (USD Million)

7.2.13.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.2.13.2    Market size, by route of administration, 2017 - 2030 (USD Million)

7.2.13.3    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.3    East North Central

7.3.1    Market size, by states, 2017 - 2030 (USD Million)

7.3.2    Market size, by application, 2017 - 2030 (USD Million)

7.3.2.1   Market size, by pain management, 2017 - 2030 (USD Million)

7.3.3    Market size, by route of administration, 2017 - 2030 (USD Million)

7.3.4    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.3.5    Illinois

7.3.5.1   Market size, by application, 2017 - 2030 (USD Million)

7.3.5.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.3.5.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.3.5.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.3.6    Michigan

7.3.6.1   Market size, by application, 2017 - 2030 (USD Million)

7.3.6.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.3.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.3.6.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.3.7    Ohio

7.3.7.1   Market size, by application, 2017 - 2030 (USD Million)

7.3.7.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.3.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.3.7.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.4    South Atlantic

7.4.1    Market size, by states, 2017 - 2030 (USD Million)

7.4.2    Market size, by application, 2017 - 2030 (USD Million)

7.4.2.1   Market size, by pain management, 2017 - 2030 (USD Million)

7.4.3    Market size, by route of administration, 2017 - 2030 (USD Million)

7.4.4    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.4.5    Delaware

7.4.5.1   Market size, by application, 2017 - 2030 (USD Million)

7.4.5.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.4.5.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.4.5.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.4.6    Florida

7.4.6.1   Market size, by application, 2017 - 2030 (USD Million)

7.4.6.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.4.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.4.6.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.4.7    Maryland

7.4.7.1   Market size, by application, 2017 - 2030 (USD Million)

7.4.7.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.4.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.4.7.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.4.8    Washington D.C.

7.4.8.1   Market size, by application, 2017 - 2030 (USD Million)

7.4.8.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.4.8.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.4.8.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.4.9    Virginia

7.4.9.1   Market size, by application, 2017 - 2030 (USD Million)

7.4.9.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.4.9.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.4.9.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.4.10    West Virginia

7.4.10.1    Market size, by application, 2017 - 2030 (USD Million)

7.4.10.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.4.10.2    Market size, by route of administration, 2017 - 2030 (USD Million)

7.4.10.3    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.5    West North Central

7.5.1    Market size, by states, 2017 - 2030 (USD Million)

7.5.2    Market size, by application, 2017 - 2030 (USD Million)

7.5.2.1   Market size, by pain management, 2017 - 2030 (USD Million)

7.5.3    Market size, by route of administration, 2017 - 2030 (USD Million)

7.5.4    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.5.5    Minnesota

7.5.5.1   Market size, by application, 2017 - 2030 (USD Million)

7.5.5.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.5.5.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.5.5.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.5.6    Missouri

7.5.6.1   Market size, by application, 2017 - 2030 (USD Million)

7.5.6.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.5.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.5.6.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.5.7    North Dakota

7.5.7.1   Market size, by application, 2017 - 2030 (USD Million)

7.5.7.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.5.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.5.7.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.5.8    South Dakota

7.5.8.1   Market size, by application, 2017 - 2030 (USD Million)

7.5.8.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.5.8.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.5.8.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.6    Pacific Central

7.6.1    Market size, by states, 2017 - 2030 (USD Million)

7.6.2    Market size, by application, 2017 - 2030 (USD Million)

7.6.2.1   Market size, by pain management, 2017 - 2030 (USD Million)

7.6.3    Market size, by route of administration, 2017 - 2030 (USD Million)

7.6.4    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.6.5    California

7.6.5.1   Market size, by application, 2017 - 2030 (USD Million)

7.6.5.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.6.5.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.6.5.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.6.6    Alaska

7.6.6.1   Market size, by application, 2017 - 2030 (USD Million)

7.6.6.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.6.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.6.6.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.6.7    Hawaii

7.6.7.1   Market size, by application, 2017 - 2030 (USD Million)

7.6.7.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.6.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.6.7.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.6.8    Oregon

7.6.8.1   Market size, by application, 2017 - 2030 (USD Million)

7.6.8.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.6.8.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.6.8.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.6.9    Washington

7.6.9.1   Market size, by application, 2017 - 2030 (USD Million)

7.6.9.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.6.9.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.6.9.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.7    Mountain States

7.7.1    Market size, by states, 2017 - 2030 (USD Million)

7.7.2    Market size, by application, 2017 - 2030 (USD Million)

7.7.2.1   Market size, by pain management, 2017 - 2030 (USD Million)

7.7.3    Market size, by route of administration, 2017 - 2030 (USD Million)

7.7.4    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.7.5    Arizona

7.7.5.1   Market size, by application, 2017 - 2030 (USD Million)

7.7.5.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.7.5.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.7.5.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.7.6    Colorado

7.7.6.1   Market size, by application, 2017 - 2030 (USD Million)

7.7.6.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.7.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.7.6.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.7.7    Nevada

7.7.7.1   Market size, by application, 2017 - 2030 (USD Million)

7.7.7.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.7.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.7.7.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.7.8    New Mexico

7.7.8.1   Market size, by application, 2017 - 2030 (USD Million)

7.7.8.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.7.8.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.7.8.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.7.9    Montana

7.7.9.1   Market size, by application, 2017 - 2030 (USD Million)

7.7.9.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.7.9.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.7.9.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.7.10    Utah

7.7.10.1    Market size, by application, 2017 - 2030 (USD Million)

7.7.10.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.7.10.2    Market size, by route of administration, 2017 - 2030 (USD Million)

7.7.10.3    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.8    West South Central

7.8.1    Market size, by states, 2017 - 2030 (USD Million)

7.8.2    Market size, by application, 2017 - 2030 (USD Million)

7.8.2.1   Market size, by pain management, 2017 - 2030 (USD Million)

7.8.3    Market size, by route of administration, 2017 - 2030 (USD Million)

7.8.4    Market size, by distribution channel, 2017 - 2030 (USD Million)

7.8.5    Arkansas

7.8.5.1   Market size, by application, 2017 - 2030 (USD Million)

7.8.5.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.8.5.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.8.5.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.8.6    Oklahoma

7.8.6.1   Market size, by application, 2017 - 2030 (USD Million)

7.8.6.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.8.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.8.6.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

7.8.7    Louisiana

7.8.7.1   Market size, by application, 2017 - 2030 (USD Million)

7.8.7.1.1    Market size, by pain management, 2017 - 2030 (USD Million)

7.8.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

7.8.7.3   Market size, by distribution channel, 2017 - 2030 (USD Million)

Chapter 8   Company Profiles

8.1    Competitive dashboard

8.2    Canopy Growth Corporation

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Service landscape

8.2.4    SWOT analysis

8.3    Aurora Cannabis, Inc.

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Service landscape

8.3.4    SWOT analysis

8.4    GW Pharmaceuticals

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Service landscape

8.4.4    SWOT analysis

8.5    Medical Marijuana, Inc.

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Service landscape

8.5.4    Strategic outlook

8.5.5    SWOT analysis

8.6    Cannabis Sativa, Inc.

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Service landscape

8.6.4    Strategic outlook

8.6.5    SWOT analysis

8.7    Emerald Health Therapeutics Inc.

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Service landscape

8.7.4    SWOT analysis

8.8    The Cronos Group Inc.

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Service landscape

8.8.4    SWOT analysis

8.9    Tilray

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Service landscape

8.9.4    SWOT analysis

8.10    Lexaria Bioscience Corp

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Service landscape

8.10.4    SWOT analysis

8.11    Curaleaf

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Service landscape

8.11.4    Strategic outlook

8.11.5    SWOT analysis

8.12    Green Roads

8.12.1    Business overview

8.12.2    Financial data

8.12.3    Service landscape

8.12.4    Strategic outlook

8.12.5    SWOT analysis

8.13    CHARLOTTE’S WEB

8.13.1    Business overview

8.13.2    Financial data

8.13.3    Service landscape

8.13.4    Strategic outlook

8.13.5    SWOT analysis

8.14    Gaia Herbs

8.14.1    Business overview

8.14.2    Financial data

8.14.3    Service landscape

8.14.4    Strategic outlook

8.14.5    SWOT analysis

8.15    Folium Biosciences

8.15.1    Business overview

8.15.2    Financial data

8.15.3    Service landscape

8.15.4    Strategic outlook

8.15.5    SWOT analysis

Authors: Mariam Faizullabhoy, Gauri Wani

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Explore Our Licensing Options:

Immediate Delivery Available

Premium Report Details

Base Year: 2021

Companies covered: 16

Tables & Figures: 413

Countries covered: 36

Pages: 225

Download Free PDF

img

U.S. Medical Marijuana Market

Get a free sample of this report
country Flag
+1
img
Get a free sample of this report U.S. Medical Marijuana Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Your personal details will remain secure and confidential.

Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!

Top
ISO CertificateISO Certified
Authorize.NetAuthorize.net
Accredited BusinessBBB A+ Accredited
vikingcloudViking Cloud Trusted
Information
Link
Global Headquarters
Global Market Insights Inc. 4 North Main Street, Selbyville, Delaware 19975 USA
Toll free : +1-888-689-0688
USA : +1-302-846-7766
APAC : +65-3129-7718
Email: [email protected]
Global Market Insights Inc. © 2026 All Rights Reserved.